Literature DB >> 22510843

The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.

Débora Alves Nunes Mario1, Laura Bedin Denardi, Laíssa Arévalo Bandeira, Milene Silva Antunes, Janio Morais Santurio, Luiz Carlos Severo, Sydney Hartz Alves.   

Abstract

The extensive use of azole antifungal agents has promoted the resistance of Candida spp to these drugs. Candida glabrata is a problematic yeast because it presents a high degree of primary or secondary resistance to fluconazole. In Brazil, C. glabrata has been less studied than other species. In this paper, we compared the activity of three major classes of antifungal agents (azoles, echinocandins and polyenes) against fluconazole-susceptible (FS) and fluconazole-resistant (FR) C. glabrata strains. Cross-resistance between fluconazole and voriconazole was remarkable. Among the antifungal agents, the echinocandins were the most effective against FS and FR C. glabrata and micafungin showed the lowest minimal inhibitory concentrations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22510843     DOI: 10.1590/s0074-02762012000300022

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  4 in total

1.  Antifungal activities of diphenyl diselenide alone and in combination with fluconazole or amphotericin B against Candida glabrata.

Authors:  Laura Bedin Denardi; Débora Alves Nunes Mario; Erico Silva de Loreto; Cristina Wayne Nogueira; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Mycopathologia       Date:  2013-06-23       Impact factor: 2.574

2.  Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile.

Authors:  Paulo Murillo Neufeld; Marcia de Souza Carvalho Melhem; Maria Walderez Szeszs; Marcos Dornelas Ribeiro; Efigênia de Lourdes Teixeira Amorim; Manuela da Silva; Marcia dos Santos Lazéra
Journal:  Braz J Microbiol       Date:  2015-06-01       Impact factor: 2.476

3.  Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.

Authors:  Yohsuke Nagayoshi; Taiga Miyazaki; Shintaro Shimamura; Hironobu Nakayama; Asuka Minematsu; Shunsuke Yamauchi; Takahiro Takazono; Shigeki Nakamura; Katsunori Yanagihara; Shigeru Kohno; Hiroshi Mukae; Koichi Izumikawa
Journal:  PLoS One       Date:  2017-07-11       Impact factor: 3.240

4.  Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.

Authors:  Catarina Savastano; Elisa de Oliveira Silva; Lindyanne Lemos Gonçalves; Jéssica Maria Nery; Naiara Chaves Silva; Amanda Latercia Tranches Dias
Journal:  Braz J Microbiol       Date:  2016-03-02       Impact factor: 2.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.